Skip to main content
Sign up for the newsletterJoin the community

Rheumatologic Disorders

  • Home
  • Rheumatologic Disorders
Image placeholder title
Rheumatologic Disorders

The Importance of the ICD-10 Code for Non-Radiographic Axial Spondyloarthritis

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Cosentyx Approved for Treatment of Non-Radiographic Spondyloarthritis (NR-SPA)

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Taltz receives the indication for treatment of Non-radiographic NR-SPA

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Hydroxychloroquine – An Old Drug for a New Disease

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Diagnosing Ankylosing Spondylitis and the Role of HLA B-27 Testing

By MedMaven
Image placeholder title
Rheumatologic Disorders

Recommendations for Exercise in Ankylosing Spondylitis

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

What does sex have to do with Ankylosing Spondylitis (AS)?

By Dr. David Borenstein
shutterstock_674652787
Rheumatologic Disorders

Rinvoq Approved for Ankylosing Spondylitis

By Dr. David Borenstein
shutterstock_570625726
Rheumatologic Disorders

Taltz Improves Arthritis of the Spine Progression

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Fast progression of radiographic changes in patients with ankylosing spondylitis

By Dr. David Borenstein
shutterstock_1794852322
Rheumatologic Disorders

Ankylosing Spondylitis (AS)

By MedMaven
Image placeholder title
Rheumatologic Disorders

Back Pain and The Covid-19 Pandemic

By Dr. David Borenstein
shutterstock_2046335624
Rheumatologic Disorders

Xeljanz (tofacitinib) First Oral Therapy Approved for Ankylosing spondylitis (AS)

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Baricitinib – Just Another Kinase (JAK) inhibitor

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Chair Selection During the Covid-19 Pandemic

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Filgotinib is rejected by the Food and Drug Administration (FDA)

By MedMaven
Image placeholder title
Rheumatologic Disorders

Psoriatic Arthritis - Spondylitis of The Spine

By MedMaven
Image placeholder title
Rheumatologic Disorders

Axial Spondyloarthropathy (axSpA)

By MedMaven
Image placeholder title
Rheumatologic Disorders

Diffuse Idiopathic Skeletal Hyperostosis (DISH)

By MedMaven
Image placeholder title
Rheumatologic Disorders

New Recommendations for the Treatment of Spondylitis

By MedMaven
Image placeholder title
Rheumatologic Disorders

Reactive Arthritis and the Spine

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Are Baricitinib and Remdesivira a Good Combination for the Treatment of Covid-19

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Enteropathic Arthritis

By MedMaven
Image placeholder title
Rheumatologic Disorders

The Effects of nonsteroidal Anti-Inflammatory drugs

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Rheumatoid Arthritis and the Spine

By MedMaven
Image placeholder title
Rheumatologic Disorders

Could Early Ankylosing Spondylitis be the Cause of Your Back Pain?

By MedMaven
pexels-markus-winkler-4057663
Rheumatologic Disorders

Apremilast – Not Effective for Every Form of Spondyloarthritis

By Dr. David Borenstein
Ankylosing Spondylitisnews3.1.1
Rheumatologic Disorders

Clearing the Confusion

By Dr. C.H. Weaver M.D.
Image placeholder title
Rheumatologic Disorders

Frequently Asked Questions About Otrexup® (methotrexate)

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Report from the 18th 2020 Spondyloarthritis Research and Treatment Network

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Report from the 18th 2020 Spondyloarthritis Research and Treatment Network

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

COVID-19 and Biologic Therapies –No Increased Risk for RA AS PsA Patients

By Dr. David Borenstein
Image placeholder title
Rheumatologic Disorders

Immunosuppressive drugs and COVID-19 –No Increased Risk

By Dr. David Borenstein